Media optimized for CHO and HEK underperforms for expansion of cell types used in cell therapy. Media development for new cell types is prohibitively expensive. These costs reduce affordability and accessibility of new therapies.
Multus develops media formulations for new cell types used in allogeneic therapies. This enables cost-efficient cell expansion.
Learn moreMedia optimized for biological and regulatory requirements.
Our automated system reduces the time and cost to develop new formulations.
We develop new formulations from the ground-up, providing flexibility on composition and licensing.
If you need animal component-free media that scales, we'd like to help. Get in touch with us using the form below.